BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14684497)

  • 1. The EUROCARE Study: strengths, limitations and perspectives of population-based, comparative survival studies.
    Berrino F
    Ann Oncol; 2003; 14 Suppl 5():v9-13. PubMed ID: 14684497
    [No Abstract]   [Full Text] [Related]  

  • 2. EUROCARE-2: relevance for assessment of quality of cancer services?
    Irwig L; Armstrong B
    Lancet; 2000 Feb; 355(9202):427-8. PubMed ID: 10841121
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction: the EUROCARE II Study.
    Berrino F; Gatta G; Chessa E; Valente F; Capocaccia R
    Eur J Cancer; 1998 Dec; 34(14 Spec No):2139-53. PubMed ID: 10070280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary.
    Sant M; Aareleid T; Berrino F; Bielska Lasota M; Carli PM; Faivre J; Grosclaude P; Hédelin G; Matsuda T; Møller H; Möller T; Verdecchia A; Capocaccia R; Gatta G; Micheli A; Santaquilani M; Roazzi P; Lisi D;
    Ann Oncol; 2003; 14 Suppl 5():v61-118. PubMed ID: 14684501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis.
    Capocaccia R; Gatta G; Roazzi P; Carrani E; Santaquilani M; De Angelis R; Tavilla A;
    Ann Oncol; 2003; 14 Suppl 5():v14-27. PubMed ID: 14684498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population-based data from EUROCARE-5.
    Trama A; Botta L; Foschi R; Ferrari A; Stiller C; Desandes E; Maule MM; Merletti F; Gatta G;
    Lancet Oncol; 2016 Jul; 17(7):896-906. PubMed ID: 27237614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Survival of cancer patients in Europe (EUROCARE study)].
    Jougla E
    Rev Epidemiol Sante Publique; 1996 Oct; 44(5):473-5. PubMed ID: 8966343
    [No Abstract]   [Full Text] [Related]  

  • 8. Childhood malignancies in the EUROCARE study: the database and the methods of survival analysis.
    Magnani C; Gatta G; Corazziari I; Kramarova E; Pastore G; Viscomi S; Stiller C
    Eur J Cancer; 2001 Apr; 37(6):678-86. PubMed ID: 11311641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas.
    Micheli A; Baili P; Quinn M; Mugno E; Capocaccia R; Grosclaude P;
    Ann Oncol; 2003; 14 Suppl 5():v28-40. PubMed ID: 14684499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The EUROCARE study of survival of cancer patients in Europe: aims, current status, strengths and weaknesses.
    Berrino F; Gatta G; Sant M; Capocaccia R
    Eur J Cancer; 2001 Apr; 37(6):673-7. PubMed ID: 11311640
    [No Abstract]   [Full Text] [Related]  

  • 11. Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis?
    Minicozzi P; Walsh PM; Sánchez MJ; Trama A; Innos K; Marcos-Gragera R; Dimitrova N; Botta L; Johannesen TB; Rossi S; Sant M;
    Eur J Cancer; 2018 Apr; 93():127-137. PubMed ID: 29518726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EUROCARE database.
    Sant M; Gatta G
    IARC Sci Publ; 1995; (132):15-31. PubMed ID: 7797292
    [No Abstract]   [Full Text] [Related]  

  • 13. Variation in survival of children with central nervous system (CNS) malignancies diagnosed in Europe between 1978 and 1992: the EUROCARE study.
    Magnani C; Aareleid T; Viscomi S; Pastore G; Berrino F;
    Eur J Cancer; 2001 Apr; 37(6):711-21. PubMed ID: 11311645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer survival in adult patients in Spain. Results from nine population-based cancer registries.
    Chirlaque MD; Salmerón D; Galceran J; Ameijide A; Mateos A; Torrella A; Jiménez R; Larrañaga N; Marcos-Gragera R; Ardanaz E; Sant M; Minicozzi P; Navarro C; Sánchez MJ;
    Clin Transl Oncol; 2018 Feb; 20(2):201-211. PubMed ID: 28718071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A re-evaluation of Eurocare 2 cancer study. Ranking of countries by survival can be misleading].
    Madsen FF; Gullacksen B; Frølund L; Nørskov B
    Ugeskr Laeger; 2002 May; 164(22):2912-3. PubMed ID: 12082820
    [No Abstract]   [Full Text] [Related]  

  • 16. Variation in survival of patients with prostate cancer in Europe since 1978. EUROCARE Working Group.
    Post PN; Damhuis RA; van der Meyden AP
    Eur J Cancer; 1998 Dec; 34(14 Spec No):2226-31. PubMed ID: 10070291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in survival for adults with nasopharyngeal cancer in Europe, 1978-1989. EUROCARE Working Group.
    Jiong L; Berrino F; Coebergh JW
    Eur J Cancer; 1998 Dec; 34(14 Spec No):2162-6. PubMed ID: 10070282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in survival from breast cancer in Europe by age and country, 1978-1989. EUROCARE Working Group.
    Quinn MJ; Martinez-Garcia C; Berrino F
    Eur J Cancer; 1998 Dec; 34(14 Spec No):2204-11. PubMed ID: 10070288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in survival of patients with cancer of the kidney in Europe. EUROCARE Working Group.
    Damhuis RA; Kirkels WJ
    Eur J Cancer; 1998 Dec; 34(14 Spec No):2232-5. PubMed ID: 10070292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eurocare.
    Mann JR
    Eur J Cancer; 2004 Jan; 40(1):8-9. PubMed ID: 14687783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.